Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 354 citing Chiasson: The efficacy of acarbose in the treatment of patients with non-insulin-dependent.... (0.09 sec) 

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial


JL Chiasson, RG Josse, R Gomis, M Hanefeld, … - The Lancet, 2002 - Elsevier
We randomly allocated 714 patients with impaired glucose tolerance to acarbose
and 715 to placebo. We excluded 61 (4%) patients because they did not have
impaired glucose tolerance or had no postrandomisation data. 211 (31%) of ...
Cited by 1208 - Related articles - All 14 versions

Pharmacologic therapy for type 2 diabetes mellitus

- annals.org [PDF] 
RA DeFronzo - Annals of internal medicine, 1999 - Am Coll Physicians
Type 2 diabetes mellitus is a chronic metabolic disorder that results from
defects in both insulin secretion and insulin action. An elevated rate of basal
hepatic glucose production in the presence of hyperinsulinemia is the pri- ...
Cited by 782 - Related articles - BL Direct - All 14 versions

Oral antihyperglycemic therapy for type 2 diabetes: scientific review

- pharmyaring.com [PDF] 
SE Inzucchi - Jama, 2002 - Am Med Assoc
Context Care of patients with type 2 diabetes has been revolutionized throughout
the past several years—first, by the realization of the importance of tight
glycemic control in forestalling complications, and second, by the ...
Cited by 600 - Related articles - BL Direct - All 18 versions

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: …

- karolinskauniversitetssjukhuset.se [PDF] 
SR Salpeter, E Greyber, GA Pasternak, EE … - Archives of Internal Medicine, 2003 - archinte.highwire.org
Methods A comprehensive search was performed to identify all comparative trials
or observational cohort studies published between January 1, 1959, and March 31,
2002, that evaluated metformin therapy, alone or in combination with other ...
Cited by 317 - Related articles - BL Direct - All 16 versions

Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review

- juanncorpas.edu.co [PDF] 
DE DeWitt, IB Hirsch - Jama, 2003 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Newer insulin ...
Cited by 273 - Related articles - BL Direct - All 8 versions

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis …

- oxfordjournals.org
M Hanefeld, M Cagatay, T Petrowitsch, D … - European heart journal, 2004 - Eur Soc Cardiology
Methods and results This meta-analysis included seven randomized, double-blind,
placebo-controlled acarbose studies with a minimum treatment duration of 52
weeks. Type 2 diabetic patients valid for safety were randomized to either ...
Cited by 258 - Related articles - All 10 versions

[PDF] Initial management of glycemia in type 2 diabetes mellitus


DM Nathan - N Engl j Med, 2002 - cme.nejm.org
After an overnight fast, an asymptomatic 45-year-old Hispanic man has a plasma
glucose level of 142 mg per deciliter (7.9 mmol per liter) on initial evaluation
and 139 mg per deciliter (7.7 mmol per liter) on reevaluation. Other than a ...
Cited by 242 - Related articles - Cached - BL Direct - All 17 versions

Pathophysiology and pharmacological treatment of insulin resistance

- endojournals.org
S Matthaei, M Stumvoll, M Kellerer, HU Haring - Endocrine Reviews, 2000 - Endocrine Soc
Diabetes mellitus type 2 is a world-wide growing health problem affecting more
than 150 million people at the beginning of the new millennium. It is believed
that this number will double in the next 25 yr. The pathophysiological ...
Cited by 204 - Related articles - BL Direct - All 5 versions

Combination therapies with insulin in type 2 diabetes

- diabetesjournals.org [PDF] 
H Yki-Järvinen - Diabetes Care, 2001 - Am Diabetes Assoc
The UK Prospective Diabetes Study (UKPDS) demonstrated that inten- sive glucose
control with insulin or sulfonylureas markedly reduces the risk of microvascular
complications (1). For myocardial infarction, the reduction in risk (16% ...
Cited by 203 - Related articles - BL Direct - All 7 versions

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic …

- diabetesjournals.org [PDF] 
RR Holman, CA Cull, RC Turner - Diabetes Care, 1999 - Am Diabetes Assoc
Patients Of 3,309 patients attending UKPDS clinics (8) between May and September
1994, 1,946 (59%) agreed to take part in a 3-year, double-blind,
placebo-controlled trial of acarbose given in addition to their pre e x- ...
Cited by 193 - Related articles - BL Direct - All 8 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google